Sio Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-75,361
Closed -$3.15M – 84
2018
Q3
$3.15M Sell
75,361
-30,039
-29% -$1.16M 1.08% 38
2018
Q2
$3.63M Buy
+105,400
New +$3.6M 2.01% 20
2018
Q1
– Sell
-105,400
Closed -$3.62M – 42
2017
Q4
$3.62M Buy
+105,400
New +$3.59M 2.04% 19
2017
Q2
– Sell
-105,400
Closed -$3.42M – 67
2017
Q1
$3.42M Buy
+105,400
New +$3.32M 1.91% 20
2016
Q3
– Sell
-189,720
Closed -$6.34M – 44
2016
Q2
$6.34M Buy
+189,720
New +$6.06M 3.24% 12
2015
Q3
– Sell
-158,100
Closed -$5.03M – 44
2015
Q2
$5.03M Buy
+158,100
New +$5.15M 2.49% 13

Other funds holding PFE

Sio Capital Management's PFE Position: Q4 2023 in Review

Sio Capital Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 450,700 shares — an estimated $14.9M sold.

Sio Capital Management first reported a position in PFE in Q3 2019 and held it in 3 quarters. The position peaked at $14.9M in Q3 2023. 2,940 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Sio Capital Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Sio Capital Management sold 450,700 Pfizer shares in Q4 2023, an estimated $14.9M.
  • Sio Capital Management first reported a position in Pfizer in Q3 2019 and held it in 3 quarters.
  • Sio Capital Management's Pfizer position peaked at $14.9M in Q3 2023.
  • 2,940 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Sio Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.